A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39+Foxp3+ T cells and Treg function

Gut Microbes

Volumn 6, Issue 4, 2015, Pages 234-242

  Telesford, Kiel M ^a   Yan, Wang ^a   Ochoa Reparaz, Javier ^a   Pant, Anudeep ^a   Kircher, Christopher ^a   Christy, Marc A ^a   Begum Haque, Sakhina ^a   Kasper, Dennis L ^b   Kasper, Lloyd H ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Autoimmunity; Bacteroides fragilis; Commensal microbiota; Dendritic cell; Ectonuclease; Foxp3; Multiple sclerosis; T regulatory cells; Zwitterionic polysaccharide

Indexed keywords

CD39 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; POLYSACCHARIDE; POLYSACCHARIDE A; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; APYRASE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE A;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTEROIDES FRAGILIS; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; NONHUMAN; REGULATORY T LYMPHOCYTE; STREPTOCOCCUS PNEUMONIAE; UPREGULATION; CD4+ T LYMPHOCYTE; CELL CULTURE; CHEMISTRY; IMMUNOLOGY; IMMUNOPHENOTYPING; PHYSIOLOGY; SYMBIOSIS; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD; APYRASE; BACTEROIDES FRAGILIS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOPHENOTYPING; LIPOPOLYSACCHARIDES; SYMBIOSIS; T-LYMPHOCYTE SUBSETS;

EID: 84944445669     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.1080/19490976.2015.1056973     Document Type: Article

References (50)

1. Wu H-J, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes 2012; 3:4-14; PMID:22356853; http://dx.doi.org/10.4161/ gmic.19320
2. Ivanov II, Honda K. Intestinal commensal microbes as immune modulators. Cell Host Microbe 2012; 12:496-508; PMID:23084918; http://dx.doi.org/ 10.1016/j.chom.2012.09.009
3. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004; 4:478-85; PMID:15173836; http://dx.doi.org/10.1038/nri1373
4. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122:107-18; PMID:16009137; http://dx.doi. org/10.1016/j.cell.2005.05.007
5. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139:485-98; PMID:19836068; http://dx.doi.org/10.1016/j. cell.2009.09.033
6. Ochoa-Repáraz J, Mielcarz DW, Ditrio LE, Burroughs AR, Begum-Haque S, Dasgupta S, Kasper DL, Kasper LH. Central nervous system demyelinating disease protection by the human commensal bacteroides fragilis depends on polysaccharide A expression. J Immunol 2010; 185:4101-8; PMID:20817872; http://dx.doi. org/10.4049/jimmunol.1001443
7. Östman S, Rask C, Wold AE, Hultkrantz S, Telemo E. Impaired regulatory T cell function in germ-free mice. Eur J Immunol 2006; 36:2336-46; PMID:16897813; http://dx.doi.org/10.1002/eji.200535244
8. Round JL, Mazmanian SK. Inducible Foxp3C regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 2010; 107:12204; PMID:20566854; http://dx.doi.org/ 10.1073/pnas.0909122107
9. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK. The Toll-Like Receptor 2 Pathway Establishes Colonization by a Commensal of the Human Microbiota. Science 2011; 332:974-7; PMID:21512004; http://dx.doi.org/10.1126/ science.1206095
10. Ochoa-Repáraz J, Mielcarz DW, Wang Y, Begum-Haque S, Dasgupta S, Kasper DL, Kasper LH. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal immunology 2010:1-9; PMID:20531465
11. Friedman DJ, Künzli BM, A-Rahim YI, Sevigny J, Berberat PO, Enjyoji K, Csizmadia E, Friess H, Robson SC. CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Natl Acad Sci U S A 2009; 106:16788-93; PMID:19805374; http:// dx.doi.org/10.1073/pnas.0902869106
12. Lu Y, Wang J, Gu J, Lu H, Li X, Qian X, Liu X, Wang X, Zhang F, Lu L. Rapamycin regulates iTreg function through CD39 and Runx1 pathways. J Immunol Res 2014:1-8; PMID:24741640
13. Wang Y, Telesford KM, Raz JO-RA, Haque-Begum S, Christy M, Kasper EJ, Wang L, Wu Y, Robson SC, Kasper DL, et al. An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling. Nat Commun 2014; 5:1-10; PMID:25043484
14. Cobb BA, Kasper DL. Zwitterionic capsular polysaccharides: the new MHCII-dependent antigens. Cell Microbiol 2005; 7:1398-403; PMID:16153240; http://dx.doi.org/10.1111/j.1462-5822.2005.00591.x
15. Cobb BA, Wang Q, Tzianabos AO, Kasper DL. Polysaccharide processing and presentation by the MHCII pathway. Cell 2004; 117:677-87; PMID:15163414; http://dx.doi.org/10.1016/j.cell.2004.05.001
16. Kalka-Moll WM, Tzianabos AO, Bryant PW, Niemeyer M, Ploegh HL, Kasper DL. Zwitterionic polysaccharides stimulate T cells by MHC class IIdependent interactions. J Immunol 2002; 169:6149-53; PMID:12444118; http://dx.doi.org/10.4049/ jimmunol.169.11.6149
17. Kreisman LSC, Cobb BA. Glycoantigens Induce Human Peripheral Tr1 Cell Differentiation with Guthoming Specialization. J Biol Chem 2011; 286:8810-8; PMID:21228275; http://dx.doi.org/10.1074/jbc. M110.206011
18. Liu W. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4C T reg cells. J ExpMed 2006; 203:1701-11; PMID:16818678; http://dx. doi.org/10.1084/jem.20060772
19. Fletcher JM, Lonergan R, Costelloe L, Kinsella K, Moran B, O'Farrelly C, Tubridy N, Mills KHG. CD39CFoxp3C regulatory T cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J Immunol 2009; 183:7602-10; PMID:19917691; http://dx.doi.org/10.4049/jimmunol.0901881
20. Baecher-Allan C, Wolf E, Hafler DA. MHC class II expression identifies functionally distinct human regulatory T cells. J Immunol 2006; 176:4622-31; PMID:16585553; http://dx.doi.org/10.4049/ jimmunol.176.8.4622
21. Chauhan SK, Saban DR, Lee HK, Dana R. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J Immunol 2008; 182:148-53; PMID:19109145; http://dx.doi.org/10.4049/ jimmunol.182.1.148
22. Tran DQ, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human CD4CFOXP3 T cells by T-cell receptor stimulation is transforming growth factor-dependent but does not confer a regulatory phenotype. Blood 2007; 110:2983-90; PMID:17644734; http://dx.doi.org/10.1182/blood-2007-06-094656
23. Pillai V, Ortega SB, Wang CK, Karandikar NJ. Transient regulatory T-cells: A state attained by all activated human T-cells. Clin Immunol 2007; 123:18-29; PMID:17185041; http://dx.doi.org/10.1016/j. clim.2006.10.014
24. Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, Roncarolo MG, Levings MK. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007; 19:345-54; PMID:17329235; http:// dx.doi.org/10.1093/intimm/dxm014
25. Allan SE, Alstad AN, Merindol N, Crellin NK, Amendola M, Bacchetta R, Naldini L, Roncarolo MG, Soudeyns H, Levings MK. Generation of potent and stable human CD4C T regulatory cells by activation-independent expression of FOXP3. Mol Ther 2007; 16:194-202; PMID:17984976; http://dx.doi.org/ 10.1038/sj.mt.6300341
26. Hippen KL, Merkel SC, Schirm DK, Nelson C, Tennis NC, Riley JL, June CH, Miller JS, Wagner JE, Blazar BR. Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versushost disease. Am J Transplant 2011; 11:1148-57; PMID:21564534; http://dx.doi.org/10.1111/j.1600-6143.2011.03558.x
27. Sawant DV, Vignali D. Once a Treg, always a Treg? Immunol Rev 2014; 259:173-91; PMID:24712466
28. Antonioli L, Pacher P, Vizi ES, Haskó G. CD39 and CD73 in immunity and inflammation. Trends Mol Med 2013; 19:355-67; PMID:23601906; http://dx. doi.org/10.1016/j.molmed.2013.03.005
29. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, Hopner S, Centonze D, Bernardi G, Dell'Acqua ML, et al. Expression of ectonucleotidase CD39 by Foxp3C Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007; 110:1225-32; PMID:17449799; http://dx.doi. org/10.1182/blood-2006-12-064527
30. Dwyer KM, Hanidziar D, Putheti P, Hill PA, Pommey S, McRae JL, Winterhalter A, Doherty G, Deaglio S, Koulmanda M, et al. Expression of CD39 by human peripheral blood CD4CCD25C T cells denotes a regulatory memory phenotype. Am J Transplant 2010; 10:2410-20; PMID:20977632; http://dx.doi.org/ 10.1111/j.1600-6143.2010.03291.x
31. Schuler PJ, Schilling B, Harasymczuk M, Hoffmann TK, Johnson J, Lang S, Whiteside TL. Phenotypic and functional characteristics of CD4CCD39C FOXP3C and CD4CCD39CFOXP3neg T-cell subsets in cancer patients. Eur J Immunol 2012; 42:1876-85:n/a-n/a; PMID:22585562
32. Bai A, Moss A, Kokkotou E, Usheva A, Sun X, Cheifetz A, Zheng Y, Longhi MS, Gao W, Wu Y, et al. CD39 and CD161 modulate Th17 responses in Crohn's disease. J Immunol 2014; 193:3366-77; PMID:25172498; http://dx.doi.org/10.4049/ jimmunol.1400346
33. Herrath J, Chemin K, Albrecht I, Catrina AI, Malmström V. Surface expression of CD39 identifies an enriched Treg-cell subset in the rheumatic joint, which does not suppress IL-17A secretion. Eur J Immunol 2014; 44:2979-89; PMID:24990235; http://dx. doi.org/10.1002/eji.201344140
34. Dasgupta S, Erturk-Hasdemir D, Ochoa-Repáraz J, Reinecker H-C, Kasper DL. Plasmacytoid Dendritic Cells Mediate Anti-inflammatory Responses to a Gut Commensal Molecule via Both Innate and Adaptive Mechanisms. Cell Host Microbe 2014; 15:413-23; PMID:24721570; http://dx.doi.org/10.1016/j. chom.2014.03.006
35. Stephen TL, Niemeyer M, Tzianabos AO, Kroenke M, Kasper DL, Kalka-Moll WM. Effect of B7-2 and CD40 signals from activated antigen-presenting cells on the ability of zwitterionic polysaccharides to induce T-Cell stimulation. Infect Immun 2005; 73:2184-9; PMID:15784561; http://dx.doi.org/10.1128/ IAI.73.4.2184-2189.2005
36. Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, Kuchroo VK, Sharpe AH. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 2009; 206:3015-29; PMID:20008522; http://dx.doi.org/ 10.1084/jem.20090847
37. Wang L, Pino-Lagos K, de Vries VC, Guleria I, Sayegh MH, Noelle RJ. Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3CCD4C regulatory T cells. Proc Natl Acad Sci U S A 2008; 105:9331-6; PMID:18599457; http://dx.doi.org/ 10.1073/pnas.0710441105
38. Ramsdell F, Ziegler SF. FOXP3 and scurfy: how it all began. Nat Pub Group 2014; 14:343-9; PMID:24722479
39. Muls N, Dang HA, Sindic CJM, van Pesch V. Fingolimod increases CD39-expressing regulatory T cells in multiple sclerosis patients. PLoS One 2014; 9: e113025; PMID:25411844; http://dx.doi.org/ 10.1371/journal.pone.0113025
40. Peelen E, Damoiseaux J, Smolders J, Knippenberg S, Menheere P, Tervaert JWC, Hupperts R, Thewissen M. Th17 expansion in MS patients is counterbalanced by an expanded CD39C regulatory T cell population during remission but not during relapse. J Neuroimmunol 2011; 240-241:97-103; PMID:22035960
41. Venken K, Hellings N, Thewissen M, Somers V, Hensen K, Rummens J-L, Medaer R, Hupperts R, Stinissen P. Compromised CD4 C CD25 highregulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 2008; 123:79-89; PMID:17897326; http://dx.doi.org/10.1111/j.1365-2567.2007.02690.x
42. Huan J, Culbertson N, Spencer L, Bartholomew R, Burrows GG, Chou YK, Bourdette D, Ziegler SF, Offner H, Vandenbark AA. Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res 2005; 81:45-52; PMID:15952173; http://dx.doi.org/10.1002/ jnr.20522
43. Haas J, Fritzsching B, Trübswetter P, Korporal M, Milkova L, Fritz B, Vobis D, Krammer PH, Suri-Payer E, Wildemann B. Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J Immunol 2007; 179:1322-30; PMID:17617625; http://dx.doi.org/10.4049/ jimmunol.179.2.1322
44. Pop SM. Single cell analysis shows decreasing FoxP3 and TGF 1 coexpressing CD4CCD25C regulatory T cells during autoimmune diabetes. J Exp Med 2005; 201:1333-46; PMID:15837817; http://dx.doi.org/ 10.1084/jem.20042398
45. Baecher-Allan CM, Costantino CM, Cvetanovich GL, Ashley CW, Beriou G, Dominguez-Villar M, Hafler DA. CD2 costimulation reveals defective activity by human CD4CCD25hi regulatory cells in patients with multiple sclerosis. J Immunol 2011; 186:3317-26; PMID:21300823; http://dx.doi.org/10.4049/ jimmunol.1002502
46. Kisielewicz A, Schaier M, Schmitt E, Hug F, Haensch GM, Meuer S, Zeier M, Sohn C, Steinborn A. A distinct subset of HLA-DR. Clin Immunol 2010; 137:209-20; PMID:20822960; http://dx.doi.org/ 10.1016/j.clim.2010.07.008
47. Louis P, Flint HJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 2009; 294:1-8; PMID:19222573; http://dx.doi.org/10.1111/j.1574-6968.2009.01514.x
48. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013; 504:451-5; PMID:24226773; http://dx. doi.org/10.1038/nature12726
49. Bhargava P, Mowry EM. Gut Microbiome and Multiple Sclerosis. Curr Neurol Neurosci Rep 2014; 14:492; PMID:25204849; http://dx.doi.org/10.1007/s11910-014-0492-2
50. Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eeckhaut V, Ballet V, Claes K, Van Immerseel F, Verbeke K, et al. A decrease of the butyrateproducing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 2014; 63:1275-83; PMID:24021287; http://dx.doi.org/10.1136/gutjnl-2013-304833